| Target Price | $8.29 |
| Price | $5.76 |
| Potential |
43.97%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Profound Medical Corp 2027 .
The average Profound Medical Corp target price is $8.29.
This is
43.97%
register free of charge
$8.54
48.20%
register free of charge
$8.21
42.55%
register free of charge
|
|
| A rating was issued by 5 analysts: 4 Analysts recommend Profound Medical Corp to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Profound Medical Corp stock has an average upside potential 2027 of
43.97%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 16.10 | 25.55 |
| 50.75% | 58.71% | |
| EBITDA Margin | -252.73% | -111.07% |
| 15.99% | 56.05% | |
| Net Margin | -264.41% | -124.90% |
| 1.51% | 52.76% |
5 Analysts have issued a sales forecast Profound Medical Corp 2026 . The average Profound Medical Corp sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Profound Medical Corp EBITDA forecast 2026. The average Profound Medical Corp EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Profound Medical Corp Analysts have issued a net profit forecast 2026. The average Profound Medical Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.41 | -0.87 |
| 25.89% | 38.30% | |
| P/E | negative | |
| EV/Sales | 6.86 |
5 Analysts have issued a Profound Medical Corp forecast for earnings per share. The average Profound Medical Corp EPS is
This results in the following potential growth metrics and future valuations:
Profound Medical Corp...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| LEEDE JONES GABLE |
Locked
➜
Locked
|
Locked | Mar 07 2026 |
| LEEDE JONES GABLE |
Locked
➜
Locked
|
Locked | Aug 15 2025 |
| LEEDE JONES GABLE |
Locked
➜
Locked
|
Locked | May 09 2025 |
| LEEDE JONES GABLE |
Locked
➜
Locked
|
Locked | May 08 2025 |
| RAYMOND JAMES LTD. |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
| RAYMOND JAMES LTD. |
Locked
➜
Locked
|
Locked | Apr 28 2025 |
| RAYMOND JAMES LTD. |
Locked
➜
Locked
|
Locked | Mar 05 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
|
Mar 07 2026 |
|
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
|
Aug 15 2025 |
|
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
|
May 09 2025 |
|
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
|
May 08 2025 |
|
Locked
RAYMOND JAMES LTD.:
Locked
➜
Locked
|
Apr 29 2025 |
|
Locked
RAYMOND JAMES LTD.:
Locked
➜
Locked
|
Apr 28 2025 |
|
Locked
RAYMOND JAMES LTD.:
Locked
➜
Locked
|
Mar 05 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


